Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1998
website : www.tianyuan.com
Main Product : Chondroitin sulfate, hyaluronic acid, glucosamine sulfate, etc.
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a leading manufacturer of pharmaceutical ingredients, specializing in the production of chondroitin sulfate, hyaluronic acid, and glucosamine sulfate. With a history dating back to 1998, the company has established a strong presence in both domestic and international markets, although it faces stiff competition from other pharmaceutical companies. The company is of medium size and continues to innovate in the field of bio-pharmaceuticals.
Liaoning Chengda Co., Ltd.
Establishment time : 1997
website : www.lncd.com
Main Product : Steel products, construction materials, machinery
Company Profile
Liaoning Chengda Co., Ltd. is a medium-sized company founded in 1997, specializing in the production and distribution of steel products, construction materials, and machinery. The company primarily serves the domestic market in China and faces competition from other similar companies in the industry. For more information, visit www.lncd.com.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1958
website : http://www.cdibp.com.cn
Main Product : vaccines, blood products, and diagnostic reagents
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a state-owned enterprise specializing in the research, development, and production of biological products. With a history dating back to 1958, the company has grown to become a key player in the global healthcare industry, providing essential vaccines, blood products, and diagnostic reagents to markets around the world. With a focus on innovation and quality, Chengdu Institute of Biological Products Co., Ltd. continues to make significant contributions to public health and disease prevention.
Sinovac Biotech Co., Ltd.
Establishment time : 2001
website : www.sinovac.com
Main Product : vaccines for infectious diseases such as hepatitis A and B, influenza, and COVID-19
Company Profile
Sinovac Biotech Co., Ltd. is a leading biopharmaceutical company in China specializing in the research, development, production, and commercialization of vaccines. Founded in 2001, the company has a strong presence in the global market with a focus on preventing infectious diseases through its innovative vaccine products.
Beijing Tiantan Biological Products Co., Ltd.
Establishment time : 1992
website : www.btbp.com.cn
Main Product : Vaccine products, blood products, diagnostic reagents
Company Profile
Beijing Tiantan Biological Products Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. Founded in 1992, the company has grown to become a key player in the healthcare industry, serving markets in China, Asia, and Africa. With a medium-sized company size, Beijing Tiantan Biological Products faces strong competition in the vaccine and blood product markets, but continues to innovate and deliver high-quality products to meet the growing demand for healthcare solutions.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : Wuhan Institute of Biological Products Co., Ltd. was established in 1965.
website :
Main Product : It is one of the largest companies in the industry.
Company Profile
For more information, visit the company's website at http://www.whbp.com.cn/.
Guangdong Changda Pharmaceutical Co., Ltd.
Establishment time : Guangdong Changda Pharmaceutical Co., Ltd. was founded in 1992.
website :
Main Product : With a large company size, Changda Pharmaceutical serves both domestic and international markets.
Company Profile
Guangdong Changda Pharmaceutical Co., Ltd. continues to grow and expand its market reach in the pharmaceutical industry.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.
website :
Main Product : With over 2000 employees, Kangtai is a major player in the biopharmaceutical industry.
Company Profile
The company's website is http://www.kangtaibio.com/ for more information.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1992 and has since become a leading biotechnology company in China.
website :
Main Product : With a large company size, Hualan Biological Engineering Inc. has established itself as a key player in the biotechnology industry.
Company Profile
With a focus on research and development, Hualan Biological Engineering Inc. continues to expand its product portfolio and reach new markets worldwide.
June 15, 2024
